CA2092565A1 - Ibuprofen-diuretic combinations - Google Patents

Ibuprofen-diuretic combinations

Info

Publication number
CA2092565A1
CA2092565A1 CA002092565A CA2092565A CA2092565A1 CA 2092565 A1 CA2092565 A1 CA 2092565A1 CA 002092565 A CA002092565 A CA 002092565A CA 2092565 A CA2092565 A CA 2092565A CA 2092565 A1 CA2092565 A1 CA 2092565A1
Authority
CA
Canada
Prior art keywords
ibuprofen
diuretic
effective amount
female
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002092565A
Other languages
English (en)
French (fr)
Inventor
Robert T. Sims
William Slivka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kenvue Brands LLC
Merck and Co Inc
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Publication of CA2092565A1 publication Critical patent/CA2092565A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002092565A 1990-09-28 1991-09-25 Ibuprofen-diuretic combinations Abandoned CA2092565A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58924290A 1990-09-28 1990-09-28
US589,242 1990-09-28

Publications (1)

Publication Number Publication Date
CA2092565A1 true CA2092565A1 (en) 1992-03-29

Family

ID=24357215

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002092565A Abandoned CA2092565A1 (en) 1990-09-28 1991-09-25 Ibuprofen-diuretic combinations

Country Status (5)

Country Link
EP (1) EP0550689A1 (enExample)
JP (1) JPH06501475A (enExample)
AU (1) AU8710691A (enExample)
CA (1) CA2092565A1 (enExample)
WO (1) WO1992005786A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462950A (en) * 1993-12-21 1995-10-31 Eli Lilly And Company Methods of treating menstrual symptoms and compositions therefore
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
JP2015520748A (ja) * 2012-05-08 2015-07-23 セリックスビオ プライヴェート リミテッド 炭酸脱水酵素活性の抑制のための組成物及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
EP0267321B1 (de) * 1986-11-14 1990-02-28 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG Ibuprofen enthaltendes Arzneimittel
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia

Also Published As

Publication number Publication date
EP0550689A4 (enExample) 1994-02-16
JPH06501475A (ja) 1994-02-17
AU8710691A (en) 1992-04-28
WO1992005786A1 (en) 1992-04-16
EP0550689A1 (en) 1993-07-14

Similar Documents

Publication Publication Date Title
US5164398A (en) Ibuprofen-antitussive combinations
EP0866713B1 (en) Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
US5374661A (en) Composition and method for transdermal delivery of diclofenac
CA2191129C (fr) Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine
JP3305315B2 (ja) 動物及び人間の疼痛及び／又は炎症の抑制時における薬剤ならびにその製造及びその使用
US4588744A (en) Method of forming an aqueous solution of 3-3-Bis(p-hydroxyphenyl)-phthalide
JP2002512194A (ja) 医原性および年齢関連性高血圧症の治療方法、およびこれに有用な医薬組成物
CA2085584C (en) Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists
US5260337A (en) Ibuprofen-muscle relaxant combinations
CA1337930C (en) Method of treating skin injuries using thromboxane a__ receptor antagonists
JPS61151125A (ja) ジヒドロコデイン／イブプロフエン薬剤組成物及び方法
CA2131802A1 (en) Antipyretic and analgesic methods and compositions containing optically pure r(-)ketoprofen
JP2003526595A (ja) 細胞媒介性免疫病の処置
JPH11509547A (ja) Ｌ−ドーパエチルエステルの医薬組成品
JPS61197517A (ja) 薬剤組成物
EP0663839A1 (en) Ibuprofen-h 2? antagonist combinations
JP3122748B2 (ja) イブプロフェン含有解熱鎮痛剤
RU2004109920A (ru) Фармацевтическая композиция, включающая лумиракоксиб
JP2834512B2 (ja) リポキシン誘導体を有効成分とする疾患治療剤
CA2092565A1 (en) Ibuprofen-diuretic combinations
JPH0489428A (ja) 多形核白血球活性化剤
FR2500303A1 (fr) Le chlorure de gallium, nouveau medicament anti-cancereux
WO1992017171A1 (en) Ibuprofen-decongestant combinations
US9867789B2 (en) Non-steroidal anti-inflammatory drugs for cough
EP0551180B1 (en) Use of bucillamine for the manufacture of a medicament for the treatment of cystinuria

Legal Events

Date Code Title Description
FZDE Dead